AI Science Tracker
EN

National Institute of Health

1 discovery from 2025

Discoveries

Identifying potential biomarkers for type 2 diabetes in the adipose tissue of older adults via multiple machine learning algorithms.

Source check: Source checked. Not independent scientific confirmation.

Finding: The full primary article identifies AIM2 and FHOD3 as candidate adipose-tissue T2D biomarkers by intersecting LASSO, SVM-RFE and RF, with GEO expression analyses and qPCR in aged/high-fat-fed mice.

Technology: three GEO transcriptomic datasets, ML feature intersection, small 65/35 human-data split, then mouse tissue qPCR and diet/age comparisons.

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
three GEO transcriptomic datasets, ML feature intersection, small 65/35 human-data split, then mouse tissue qPCR and diet/age comparisons.
Test and result
The human held-out set is only 11 samples and biological follow-up is in mice; approve narrowly as exploratory candidate biomarkers, not validated human diagnostic targets.
Limitation / still unknown
The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://www.nature.com/articles/s41598-025-29141-9

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.